Originally inspired by my father's battle with multiple sclerosis, which led to foot drop, the EvoWalk has come a long way since its inception. Since January 2024, it has transformed into an FDA-cleared Class II wearable device, leveraging functional electrical stimulation (FES) to aid ankle dorsiflexion and knee flexion or extension in adults grappling with muscle weakness due to upper motor neuron diseases or injuries like stroke or spinal cord damage.